Valion Bio (VBIO) Cash from Investing Activities (2022 - 2025)
Valion Bio (VBIO) posted quarterly Cash from Investing Activities of -$149000.0 for Q4 2025, down 1390.0% quarter-over-quarter from -$10000.0 in Q3 2025.
Valion Bio (VBIO) Cash from Investing Activities (2022 - 2025) Analysis & Trends
Valion Bio's Cash from Investing Activities history runs 3 years deep, the most recent figure standing at -$149000.0 for Q4 2025.
- In Q4 2025, Cash from Investing Activities changed N/A year-over-year to -$149000.0; the TTM figure through Dec 2025 stood at -$705000.0 (down 2837.5% YoY), while the FY2025 annual figure was -$705000.0, changed N/A from the prior year.
- Cash from Investing Activities for Q4 2025 stood at -$149000.0, down from -$10000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was -$5000.0 in Q3 2022, with the low at -$526000.0 in Q1 2025.
- The 3-year median for Cash from Investing Activities is -$22000.0 (2023), against an average of -$104250.0.
- Peak annual rise in Cash from Investing Activities reached 1466.67% in 2023, while the deepest fall reached 1466.67% in 2023.
- Valion Bio's Cash from Investing Activities stood at -$5000.0 in 2022, then plunged by 380.0% to -$24000.0 in 2023, then plunged by 520.83% to -$149000.0 in 2025.
- Business Quant data shows VBIO's Cash from Investing Activities at -$149000.0 in Q4 2025, -$10000.0 in Q3 2025, and -$20000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 329.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -49.35 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -363.46 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3.17 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 24.51 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -229.72 Mn |
| 10 | Valion Bio | 405,599.63 | -1.79 Mn | -45,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -149,000.00 |
| Dec 31, 2025 | -149,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Jun 30, 2025 | -20,000.00 |
| Jun 30, 2025 | -20,000.00 |
| Mar 31, 2025 | -526,000.00 |
| Mar 31, 2025 | -526,000.00 |
| Jun 30, 2023 | -24,000.00 |
| Jun 30, 2023 | -24,000.00 |
| Mar 31, 2023 | -94,000.00 |
| Mar 31, 2023 | -94,000.00 |
| Sep 30, 2022 | -5,000.00 |
| Sep 30, 2022 | -5,000.00 |
| Mar 31, 2022 | -6,000.00 |
| Mar 31, 2022 | -6,000.00 |